RÉSUMÉ
Resumen Los tumores malignos de glándulas salivales (TMGS) constituyen un grupo infrecuente de cánceres de una gran variedad histológica. Dentro de las neoplasias de estirpe epitelial encontramos al carcinoma de células acinares (CCA), que representa entre un 6%-10% de todos los TMGS. No posee patrones clínicos ni radiológicos específicos, pero comparte características comunes con otros TMGS que serán discutidas a lo largo del reporte. Cabe destacar que en términos generales es un cáncer de bajo grado y poco recidivante, por lo que un tratamiento oportuno y un seguimiento estricto mejoran el pronóstico para este tipo de pacientes. Su diagnóstico se establece con evidencia histopatológica que confirme la presencia de diferenciación epitelial de tipo acinar. El tratamiento consiste en la exéresis tumoral con márgenes libres por parotidectomía suprafacial o total, asociado a vaciamiento cervical si se detecta compromiso nodal. Adicionalmente, se debe sugerir terapia adyuvante ante la presencia de un factor de mal pronóstico. Se presenta un caso y se realiza revisión de literatura.
Abstract Malignant salivary gland tumors (TMGS) constitute an infrequent group of cancers of a wide histological variety. Within the epithelial lineage neoplasms, we find acinar cell carcinoma that represent between 6%-10% of all TMGS. It does not have specific clinical or radiological patterns, but it shares common characteristics with other TMGS that will be discussed throughout the report. It should be noted that in general terms it is a low-grade cancer with low recurrence rates, so timely treatment and strict follow-up improve the prognosis for this type of patient. Its diagnosis is established with histopathological evidence that confirms the presence of acinar-type epithelial differentiation. Treatment consists of tumor excision with free margins by suprafacial or total parotidectomy, associated with cervical lymph node dissection if nodal locoregional metastasis is detected. Additionally, adjuvant therapy should be suggested in the presence of a poor prognostic factor. A case is presented and a literature review is carried out.
Sujet(s)
Humains , Mâle , Sujet âgé , Tumeurs de la parotide/diagnostic , Carcinome à cellules acineuses/diagnostic , Pronostic , Tumeurs de la parotide/thérapie , Tomodensitométrie/méthodes , Carcinome à cellules acineuses/thérapieRÉSUMÉ
Background: Epidermal growth factor receptor (EGFR) is potential prognostic biomarker expressed in many human cancers. Prognostic significance of EGFR immunohistochemical expression has not been established in prostatic acinar adenocarcinoma, therefore we aimed to evaluate the frequency of expression of EGFR in prostatic adenocarcinoma and its association with other prognostic parameters. Methods: The study included 123 cases of biopsy proven prostatic acinar adenocarcinoma treated at Liaquat National hospital, Karachi from January 2013 till December 2017. Paraffin blocks of all cases were retrieved; sections were cut and stained with haematoxylin and eosin. Pathologic characteristics including tumor quantification, WHO grade group, gleason score, perineural and lymphovascular invasion were evaluated. EGFR immunohistochemistry (IHC) was performed on all tissue blocks. Results: Mean age of the patients included in the study was 69.05±8.68years. High gleason scores i.e. 8 & 9 were noted in 22% (27 cases) and 22.8% (28 cases) respectively. Similarly, 22.8% (28 cases) showed WHO grade group 5. 52.8% (65 cases) had > 50% tissue involvement by carcinoma and perineural invasion was seen in 37.4% (46 cases). Positive EGFR expression was noted in 18.7% (23 cases), while 81.3% (100 cases) showed negative EGFR expression. Significant association of EGFR expression was noted with gleason score (p-value = < 0.001), WHO grade (p = < 0.001), tumor quantification (p =0.007) and perineural invasion (p = < 0.001). Moreover, significant association of EGFR expression was also seen with disease recurrence and Her2neu over expression. Patients with low gleason scores (score 6 and 7) and lower grade group (1, 2 & 3) were less likely to have positive EGFR expression as compared to patients with high gleason score (score 9) and higher grade group (5). Similarly, patients with perineural invasion were more likely to have positive EGFR expression. Conclusion: We found a relatively low EGFR expression in our patients with prostatic adenocarcinoma; however, its association with poor prognostic parameters like high gleason score, higher grade group, perineural invasion, higher tissue involvement by cancer and disease recurrence signifies its importance as a prognostic parameter in prostatic acinar adenocarcinoma (AU)
Sujet(s)
Humains , Mâle , Adulte d'âge moyen , Sujet âgé , Sujet âgé de 80 ans ou plus , Tumeurs de la prostate/anatomopathologie , Carcinome à cellules acineuses/anatomopathologie , Récepteurs ErbB/analyse , Pronostic , Tumeurs de la prostate/diagnostic , Tumeurs de la prostate/génétique , Marqueurs biologiques tumoraux , Carcinome à cellules acineuses/diagnostic , Carcinome à cellules acineuses/génétique , Survie sans rechute , Grading des tumeursRÉSUMÉ
Introducción: Los tumores malignos pancreáticos en pediatría son extremadamente infrecuentes. La sobrevida en el cáncer pancreático a cinco años es baja. Objetivo: Informar a la comunidad médica acerca de una variante poco frecuente de tumor maligno pancreático en edad pediátrica. Presentación del caso: Paciente masculino de 17 años de edad, de la raza negra, que asiste a consulta en julio de 2017 por dolor en hemiabdomen superior, se considera una gastritis y se medica con dieta y antiácidos. Posteriormente comienza con dolor abdominal recurrente, pérdida de peso, anorexia, dispepsias, ictericia en piel y mucosas. Acude al gastroenterólogo quien indica una endoscopia digestiva alta y realiza el diagnóstico del tumor mediante biopsia endoscópica transduodenal. Se opera y reseca gran tumor de cabeza del páncreas junto con primera, segunda y tercera porción del duodeno (pancreatoduodenectomía). El tumor en conjunto midió aproximadamente 15 X 20 cm de diámetro y fue una cirugía completa sin lesión microscópica residual. El resultado de la biopsia indicó que se trataba de un adenocarcinoma acinar del páncreas pobremente diferenciado. Conclusión: Existen pocos casos publicados en la edad pediátrica con esta variante de tumor pancreático. Se documenta la importancia de la cirugía en la cura de la enfermedad(AU)
Introduction: Pancreatic malignancies in pediatrics are extremely infrequent, among them ductal adenocarcinoma and acinar adenocarcinoma. Survival in pancreatic cancer at five years is low. Objective: To inform the medical community about an uncommon variant of pancreatic malignant tumor in pediatric age. Case presentation: Male patient of 17 yesar of age, of the black race, who attended consultation in July of 2017 for pain in upper abdomen, is considered a gastritis and is medicated with diet and antacids. Subsequently begins with recurrent abdominal pain, weight loss, anorexia, dyspepsia, and skin and mucous. Go to the gastroenterologist who indicates an upper gastrointestinal endoscopy and perform the diagnosis of the tumor by transduodenal endoscopic biopsy. A large head tumor of the pancreas is operated on and resected together with the first, second and third portion of the duodenum (pancreatoduodenectomy). The tumor as a whole measured approximately 15 X 20 cm in diameter and was a complete surgery without residual microscopic lesion. The result of the biopsy indicated that it was an acinar adenocarcinoma of the poorly differentiated pancreas. Conclusion: There are few cases published in the pediatric age with this variant of pancreatic tumor. The importance of surgery in the cure of the disease is documented(AU)
Sujet(s)
Humains , Mâle , Adolescent , Tumeurs du pancréas/complications , Carcinome à cellules acineuses/diagnostic , Carcinome à cellules acineuses/radiothérapie , Carcinome à cellules acineuses/traitement médicamenteuxRÉSUMÉ
Lysozyme is an enzymatic marker of acinar and intercalated duct cells of normal salivary glands. The aim of this study was to verify whether lysozyme expression could be useful to distinguish acinic cell carcinoma (ACC) from its main mimic, mammary analog secretory carcinoma (MASC). For comparison, DOG1 expression was analyzed as well. Seventeen cases of ACC, 15 MASC, and 125 other salivary tumors were studied. Lysozyme expression was found in tumor cells as well as in secreted material of MASC (86.6 % of cases) and in ductal cells of epithelial-myoepithelial carcinoma (EMC-53.8 %), pleomorphic adenoma (PA-29.1 %) and polymorphous low-grade adenocarcinoma (PLGA-23.8 %). However, in ACC, lysozyme was not expressed. Three patterns of DOG1 staining were seen: apical-luminal, cytoplasmic, and mixed cytoplasmic/membranous. The apical-luminal pattern was detected in ductal cells of ACC (58.8 % of cases), EMC (38.4 %), adenoid-cystic carcinoma (AdCC-35.3 %), PA (8.3 %), and PLGA (4.8 %). These tumors also showed mixed membranous/cytoplasmic staining for DOG1. MASC, mucoepidermoid, and salivary duct carcinomas exhibited only DOG1 cytoplasmic staining. In conclusion, lysozyme cannot be used as a marker of acinar differentiation in salivary tumors. However, lysozyme expression can be helpful to distinguish MASC from ACC due to its high frequency in the former and absence in ACC. It is likely that in MASC, lysozyme expression may reflect a lactational-like secretory differentiation since lysozyme belongs to breast milk proteins. Regarding DOG1 expression, the apical-luminal pattern is related to acinar and intercalated duct differentiation whereas the cytoplasmic staining does not seem to be associated with a specific cellular phenotype.
Sujet(s)
Marqueurs biologiques tumoraux/analyse , Carcinome à cellules acineuses/diagnostic , Carcinome sécrétoire pseudomammaire/diagnostic , Lysozyme/biosynthèse , Tumeurs des glandes salivaires/diagnostic , Adulte , Sujet âgé , Carcinome à cellules acineuses/enzymologie , Diagnostic différentiel , Femelle , Humains , Immunohistochimie , Mâle , Carcinome sécrétoire pseudomammaire/enzymologie , Adulte d'âge moyen , Lysozyme/analyse , Tumeurs des glandes salivaires/enzymologie , Jeune adulteRÉSUMÉ
Pancreatic disorders, such as chronic or acute pancreatitis, and carcinoma may be infrequently accompanied or preceded by panniculitis or polyarthritis. This triad is known in the literature as the pancreatitis, panniculitis, and polyarthritis syndrome. Although the pancreatic disease of pancreatitis, panniculitis, and polyarthritis syndrome usually includes pancreatitis, here we review the literature with report of 1 additional case of polyarthritis and panniculitis occurring in the presence of pancreatic carcinoma. Given that the diagnosis is often difficult when abdominal symptoms are absent, knowledge of the association between panniculitis and polyarthritis with pancreatic disease may lead to a prompt diagnosis and management. The histopathology of the skin lesions can be a valuable clue for focusing attention to a pancreatic disease.
Sujet(s)
Arthrite/diagnostic , Carcinome à cellules acineuses/secondaire , Tumeurs du foie/secondaire , Tumeurs du pancréas/complications , Panniculite/diagnostic , Sujet âgé , Anti-inflammatoires non stéroïdiens/usage thérapeutique , Arthrite/complications , Arthrite/traitement médicamenteux , Ponction-biopsie à l'aiguille , Carcinome à cellules acineuses/complications , Carcinome à cellules acineuses/diagnostic , Évolution de la maladie , Issue fatale , Humains , Immunohistochimie , Tumeurs du foie/complications , Tumeurs du foie/traitement médicamenteux , Mâle , Tumeurs du pancréas/diagnostic , Pancréatite/complications , Pancréatite/diagnostic , Panniculite/complications , Panniculite/traitement médicamenteux , Prednisolone/usage thérapeutiqueRÉSUMÉ
Parotid acinic cell carcinoma is a rare malignancy in childhood. We report the case of a 12-year old girl presenting with a palpable mass in the left maxillofacial area. The radiologic evaluation showed a parotid mass. Tumour resection revealed acinic cell carcinoma of the parotid gland. She underwent complementary total parotidectomy without any adjuvant treatment. The patient has been disease-free for the last five years. We review the literature on acinic cell carcinomas of parotid glands in childhood.
El carcinoma de células acinosas de la parótida es una malignidad rara en la niñez. Reportamos el caso de una niña de 12 años con una masa palpable en el área maxilofacial izquierda. La evaluación radiológica mostró una masa parótida. La resección del tumor reveló un carcinoma celular de la glándula parótida. Fue sometida a una parotidectomía total complementaria sin tratamiento adyuvante alguno. La paciente ha estado libre de enfermedad durante los últimos cinco años. Revisamos la literatura sobre carcinomas de células acinosas en las glándulas parótidas en niños.
Sujet(s)
Enfant , Femelle , Humains , Carcinome à cellules acineuses/anatomopathologie , Tumeurs de la parotide/anatomopathologie , Carcinome à cellules acineuses/diagnostic , Carcinome à cellules acineuses/chirurgie , Procédures de chirurgie maxillofaciale et buccodentaire , Tumeurs de la parotide/diagnostic , Tumeurs de la parotide/chirurgieRÉSUMÉ
Parotid acinic cell carcinoma is a rare malignancy in childhood. We report the case of a 12-year-old girl presenting with a palpable mass in the left maxillofacial area. The radiologic evaluation showed a parotid mass. Tumour resection revealed acinic cell carcinoma of the parotid gland. She underwent complementary total parotidectomy without any adjuvant treatment. The patient has been disease-free for the last five years. We review the literature on acinic cell carcinomas of parotid glands in childhood.
Sujet(s)
Carcinome à cellules acineuses/anatomopathologie , Tumeurs de la parotide/anatomopathologie , Carcinome à cellules acineuses/diagnostic , Carcinome à cellules acineuses/chirurgie , Enfant , Femelle , Humains , Procédures de chirurgie maxillofaciale et buccodentaire , Tumeurs de la parotide/diagnostic , Tumeurs de la parotide/chirurgieRÉSUMÉ
Acinic cell carcinoma (ACC) is an uncommon salivary gland tumor that primarily affects the parotid gland. Involvement of minor salivary glands is rare. This report describes a 47-year-old man with an ACC on the left buccal mucosa. Histologically, the tumor was characterized by cells that resembled the serous cells. The patient was treated with surgical excision and showed no signs of recurrence two years later.
Sujet(s)
Carcinome à cellules acineuses/diagnostic , Tumeurs de la bouche/diagnostic , Biopsie , Diagnostic différentiel , Études de suivi , Humains , Mâle , Adulte d'âge moyen , Muqueuse de la bouche/anatomopathologieRÉSUMÉ
Carcinomatous encephalitis is a rare entity, originally described by Madow and Alpers in 1951, which is characterized by tumoral spreading perivascular, without mass effect. Clinical manifestations such as hemiparesis, seizures, ataxia, speech difficulties, cerebrospinal fluid findings as well as computed tomography are nonspecific. This leads the physician to pursue more frequent diseases that could explain those manifestations--toxic, metabolic, and/or infectious encephalopathy. A magnetic resonance imaging (MRI) with gadolinium, the method of choice, presumes the diagnosis. Previous reports of this unusual form of metastatic disease have described patients with prior diagnosis of pulmonary adenocarcinoma. We present the case of carcinomatous encephalitis in a 76-year-old woman as the primary manifestation of occult pulmonary adenocarcinoma with its clinical, imaging, and anatomopathological findings.
Sujet(s)
Tumeurs du cerveau/secondaire , Carcinome à cellules acineuses/secondaire , Tumeurs du poumon/anatomopathologie , Sujet âgé , Tumeurs du cerveau/diagnostic , Tumeurs du cerveau/thérapie , Carcinome à cellules acineuses/diagnostic , Carcinome à cellules acineuses/thérapie , Femelle , Humains , Tumeurs du poumon/thérapie , Imagerie par résonance magnétiqueRÉSUMÉ
Carcinomatous encephalitis is a rare entity, originally described by Madow and Alpers in 1951, which is characterized by tumoral spreading perivascular, without mass effect. Clinical manifestations such as hemiparesis, seizures, ataxia, speech difficulties, cerebrospinal fluid findings as well as computed tomography are nonspecific. This leads the physician to pursue more frequent diseases that could explain those manifestations - toxic, metabolic, and/or infectious encephalopathy. A magnetic resonance imaging (MRI) with gadolinium, the method of choice, presumes the diagnosis. Previous reports of this unusual form of metastatic disease have described patients with prior diagnosis of pulmonary adenocarcinoma. We present the case of carcinomatous encephalitis in a 76-years-old woman as the primary manifestation of occult pulmonary adenocarcinoma with its clinical, imaging, and anatomopathological findings.
A "encefalite" carcinomatosa é entidade rara, descrita originalmente por Madow e Alpers em 1951 e caracterizada pela disseminação tumoral perivascular, sem causar efeito de massa. As manifestações clínicas como hemiparesia, convulsões, ataxia, alterações de fala, os achados do líquido cefalorraquidiano e da tomografia computadorizada de crânio são inespecíficos, o que faz buscar outras causas mais freqüentes que justifiquem o quadro -encefalopatia tóxica, metabólica e/ou infecciosa. A ressonância magnética com gadolínio é o exame de eleição, frente à suspeita clínica. Todos os casos de "encefalite" carcinomatosa foram relatados em pacientes com diagnóstico prévio de adenocarcinoma de pulmão. Nesse sentido. Apresentamos caso de encefalite carcinomatosa, em mulher de 76 anos como manifestação primária de adenocarcinoma de pulmão oculto, com seus aspectos clínicos, de imagem e anatomopatológicos.
Sujet(s)
Sujet âgé , Femelle , Humains , Tumeurs du cerveau/secondaire , Carcinome à cellules acineuses/secondaire , Tumeurs du poumon/anatomopathologie , Tumeurs du cerveau/diagnostic , Tumeurs du cerveau/thérapie , Carcinome à cellules acineuses/diagnostic , Carcinome à cellules acineuses/thérapie , Tumeurs du poumon/thérapie , Imagerie par résonance magnétiqueRÉSUMÉ
Prostatic needle biopsies from 142 patients were studied: 61 cases were "benign", 19 atypical small acinar proliferation, 31 high-grade prostatic intraepithelial neoplasia, and 31 adenocarcinoma. Using univariate analysis of 46 previously described morphological features, 16 variables were selected, which were followed by multivariate discriminant analysis. Of these parameters, seven (glandular fusion, crystalloids, nucleolomegaly, papillary architecture, visibility of basal cell layer, areas of normal luminal cell nucleus/cytoplasm ratio and areas of high luminal cell nucleus/cytoplasm ratio) remained significant in discriminating the groups. Multivariate analysis selected a small panel of histological features as those most helpful in the differential diagnosis of proliferative lesions in prostate biopsies.